Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (28 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 15 Mar 2022 – 20 Aug 2026, limited by SBI MultiCap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI MultiCap Fund | Nifty 500 |
|---|---|---|
| 15 Mar 2022 | ₹100.00 | ₹100.00 |
| 28 Jul 2022 | ₹100.85 | ₹101.78 |
| 10 Dec 2022 | ₹106.43 | ₹111.23 |
| 24 Apr 2023 | ₹102.04 | ₹105.02 |
| 06 Sep 2023 | ₹119.48 | ₹121.59 |
| 19 Jan 2024 | ₹129.97 | ₹137.92 |
| 02 Jun 2024 | ₹141.59 | ₹148.45 |
| 14 Oct 2024 | ₹167.74 | ₹166.91 |
| 26 Feb 2025 | ₹147.61 | ₹143.63 |
| 11 Jul 2025 | ₹169.39 | ₹163.78 |
| 23 Nov 2025 | ₹168.32 | ₹167.35 |
| 07 Apr 2026 | ₹150.93 | ₹149.81 |
| 20 Aug 2026 | ₹171.68 | ₹165.40 |
| Metric | SBI · Regular · IDCW NAV ₹17.48 Very High risk ★★★★★ | Category median Multi Cap Fund · 28 funds |
|---|---|---|
| +1.62% | +4.94% | |
| +14.49% | +10.91% | |
| — | +10.25% | |
| — | +6.97% | |
| +12.97% | +12.72% | |
| +12.29% | — | |
| +16.68% | +14.29% | |
| — | +11.03% | |
| — | +5.66% | |
| Risk | ||
| 12.89% | 15.45% | |
| 0.62 | 0.28 | |
| 0.84 | 0.37 | |
| -15.59% | -22.16% | |
| Nifty 500 | — | |
| +2.17% | -0.86% | |
| 0.88 | 1.02 | |
| 94.4% | 101.7% | |
| 79.6% | 103.8% | |
| 1.87% | 2.17% | |
| ₹22,997Cr | ₹3,638Cr | |
| Up to 0.25% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 30% | 53% | |
| Rama Srinivasan | — | |
| 15 Mar 2022 | — | |
| 63 | — | |
| 35.4% | — | |
| 3.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.